Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | ERY974 |
Trade Name | |
Synonyms | ERY-974|ERY 974 |
Drug Descriptions |
ERY974 is a bispecific antibody targeting both glypican 3 (GPC3) and CD3, which may enhance immune response against GPC3-expressing tumor cells (PMID: 28978751, PMID: 32247040, PMID: 31510063). |
DrugClasses | CD3 Antibody 93 GPC3 Antibody 4 |
CAS Registry Number | NA |
NCIT ID | C129936 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ERY974 | ERY974 | 0 | 1 |
ERY974 + STA551 | ERY974 STA551 | 0 | 0 |